Us Antibiotics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for US ANTIBIOTICS, and what generic and branded alternatives to US ANTIBIOTICS drugs are available?
US ANTIBIOTICS has fifteen approved drugs.
Drugs and US Patents for Us Antibiotics
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Us Antibiotics | AUGMENTIN ES-600 | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 050755-001 | Jun 22, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Us Antibiotics | AUGMENTIN '400' | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 050726-002 | May 31, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Us Antibiotics
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | 6,878,386 | ⤷ Try a Trial |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | 6,746,692 | ⤷ Try a Trial |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | 7,217,430 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for US ANTIBIOTICS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 1000 mg/62.5 mg | ➤ Subscribe | 2009-01-21 |
Similar Applicant Names
Here is a list of applicants with similar names.